Full Episode
Sunday, Sep 7
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

We're not going anywhere.

Stand up for truly independent, trusted news that you can count on!
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

food and drug administration

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Jun 10

FDA advisers back Alzheimer’s drug that can slow disease

By Matthew Perrone, Associated Press

If the agency agrees with the panel's recommendation, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. shown to convincingly slow cognitive decline and memory problems due to Alzheimer's.

Continue reading

May 15

How bird flu puts workers on farms and in food processing plants at higher risk

By Laura Santhanam

Workers on the front lines may be handling animals and food products before they have been treated for possible bird flu contamination.

Continue reading

Mar 07

Cinnamon sold at discount stores recalled due to lead content

By JoNel Aleccia, Associated Press

Dollar Tree and Family Dollar stores have removed the cinnamon from their store shelves, a company spokesperson said. Customers can return products to nearby stores for a refund.

Continue reading

Jan 21

Watch 5:46
Lead-contaminated applesauce pouches expose issues with food safety oversight

By John Yang, Andrew Corkery, Claire Mufson, Juliet Fuisz

The effects of an Oct. 2023 recall of applesauce pouches with high concentrations of lead are widening, raising questions about how food reaches store shelves, who watches over it and how far that oversight extends. Helena Bottemiller Evich, founder and…

Continue watching

Jan 07

Watch 6:21
Investigation raises new questions about Philips breathing devices after 2021 recall

By Ali Rogin, Andrew Corkery, Harry Zahn

In 2021, a widely used breathing device manufactured by Philips was the subject of a safety recall. Now, new reporting shows that the replacement machines sent out to customers might also pose dangerous problems. Ali Rogin speaks with Debbie Cenziper,…

Continue watching

Dec 09

Watch 5:08
Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’

By John Yang, Claire Mufson, Harry Zahn

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale…

Continue watching

Dec 08

Gene therapies for sickle cell disease approved in U.S.

By Laura Ungar, Associated Press

Regulators on Friday approved two new gene therapies for sickle cell disease that doctors hope can cure the painful, inherited blood disorder that afflicts mostly Black people in the United States.

Continue reading

Oct 31

WATCH: Sickle cell gene therapy gets review from FDA advisory committee

By Laura Ungar, Associated Press

If approved, it would be the first gene therapy on the U.S. market based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.

Continue reading

Oct 28

Watch 6:02
Investigation finds Philips hid safety issues with its CPAP machines for years

By Ali Rogin, Andrew Corkery

CPAP machines help about 8 million Americans with sleep-related breathing disorders, like sleep apnea, by keeping their airways open while they sleep. But one manufacturer, Philips Respironics, is coming under fire for a critical change it made to millions of…

Continue watching

Oct 28

What an FDA advisory panel’s finding that oral phenylephrine is ineffective means for cold and flu meds

By Lucas A. Berenbrok, Colleen Culley, Karen Steinmetz Pater, The Conversation

The ramp-up to cold and flu season is a bad time for consumers to learn that some of their most trusted go-to products don’t actually work.

Continue reading

Jump to the First Page Previous Page
1 2 3 4 5 6 7 8 9 18
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Sunday, Sep 7
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You